An enzyme called GAPDH is believed to play a major role in neurodegenerative diseases like Alzheimer's, Parkinson's and Huntington's disease. A component of aspirin can bind to GAPDH and block cell death associated with these neurodegenerative diseases, revealed a new study.
Study co-author Solomon Snyder, professor of neuroscience at Johns Hopkins University in Baltimore, said, "The enzyme GAPDH, long thought to function solely in glucose metabolism, is now known to participate in intra-cellular signaling. The new study establishes that GAPDH is a target for salicylate drugs related to aspirin and hence may be relevant to the therapeutic actions of such drugs."
Can Aspirin be Prescribed for Prevention of Cancer?
Newer studies are being carried out to study the role of aspirin in cancer prevention and preventing cancer death.
Advertisement
‘A component of aspirin can bind to an enzyme called GAPDH, which is believed to play a major role in neurodegenerative diseases like Alzheimer's, Parkinson's and Huntington's disease.’
Tweet it Now
Salicylic acid is the primary breakdown product of aspirin. Klessig explained, "A better understanding of how salicylic acid and its derivatives regulate the activities of the key protein can lead to the development of new and better salicylic acid-based treatments of a wide variety of devastating diseases."
Klessig further added, "A better understanding of how salicylic acid and its derivatives regulate the activities of GAPDH and HMGB1, coupled with the discovery of much more potent synthetic and natural derivatives of salicylic acid, provide great promise for the development of new and better salicylic acid-based treatments of a wide variety of prevalent, devastating diseases."
The study appeared in PLOS ONE.
Source: IANS
The study appeared in PLOS ONE.
Source: IANS
Low-Dose Aspirin for Primary Prevention of Ischemic Stroke Among Diabetic Patients
Low-dose aspirin therapy was evaluated in a retrospective cohort study to see its effect in the primary prevention of ischemic stroke among patients with diabetes.
Advertisement
 Aspirin Administration in Acute Ischemic Stroke Patients Treated With AlteplaseA three month treatment with 300 mg IV aspirin does not improve the functional outcome of alteplase-treated acute ischemic stroke patients. However, the risk of developing SICH and SAEs is enhanced. | Advertisement
|
Recurrence of Venous Thromboembolism can be Checked By Aspirin
Venous thromboembolism is the formation of blood clot in the deep veins of the body such as in legs. It can be cured by aspirin administration. Aspirin is a potent pain killer.
Advertisement
